Subscale Validation of the Neuropsychiatric Inventory Questionnaire: Comparison of Alzheimer's Disease Neuroimaging Initiative and National Alzheimer's Coordinating Center Cohorts
Paula T. Trzepacz(Indiana University School of Medicine), Jeffrey L. Cummings(University of California, Los Angeles), Peng Yu(Eli Lilly (United States)), Brian A. Willis(Eli Lilly (United States)), Jia Sun(Beike Biotechnology (China)), Ellen B. Dennehy(Purdue University West Lafayette), Phani Bhamditipati(Eli Lilly (United States)), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative)
Cited by 51
Related Papers
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
Alzheimer's disease
|Nature Reviews Disease Primers|2015|1.8k
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
|Psychological Medicine|2004|989